Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 1, 2004, Pages 251-254

  Sofianou, D ^a   Pournaras, S ^b   Giosi, M ^a   Polyzou, A ^a   Maniatis, A N ^b   Tsakris, A ^c  

^a Aristotle University of Thessaloniki   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Genotyping; Surveillance; VRE

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM ISOLATE; CLASSIFICATION; CLONAL VARIATION; CONTROLLED STUDY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; EPIDEMIC; FECES ANALYSIS; GREECE; HEALTH SURVEY; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; STREPTOCOCCUS INFECTION;

BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CARRIER STATE; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DATA COLLECTION; ENTEROCOCCUS; FECES; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; GREECE; HUMANS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC); TIME FACTORS; VANCOMYCIN RESISTANCE;

EID: 3543067067     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh293     Document Type: Article

References (14)

1. Leclerq, R., Derlot, E., Duval, J. et al. (11988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New England Journal of Medicine 319, 157-61.
2. Low, D. E., Keller, N., Barth, A. et al. (2001). Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clinical Infectious Diseases 32, Suppl. 2, 133-45.
3. Hospital Infection Control Practices Advisory Committee (HIC-PAC) (1995). Recommendations for preventing the spread of vancomycin resistance. Infection Control and Hospital Epidemiology 16, 105-13.
4. Patel, R. (2003). Clinical impact of vancomycin-resistant enterococci. Journal of Antimicrobial Chemotherapy 51, Suppl. 3,13-21.
5. Maniatis, A. N., Pournaras, S., Kanellopoulou, M. et al. (2001). Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in, a tertiary Greek hospital. Journal of Clinical Microbiology 39, 4571-4.
6. Pournaras, S., Malamou-Lada, H., Maniati, M. et al. (2004). Persistence of a clone of glycopeptide-resistant Enterococcus faecalis among patients in an intensive care unit of a Greek hospital. Journal of Antimicrobial Chemotherapy 53, 109-12.
7. Dutka-Malen, A., Evens, S. & Courvalin, P. (1995). Detection of glycopeptide resistance phenotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology 33, 24-7.
8. National Commitee for Clinical Laboratory Standards (2003). Performance Standards for Antimicrobial Susceptibility Testing: Thirteenth International Supplement M100-S13, Table 2D. NCCLS, Wayne, PA, USA.
9. Fines, M., Perichon, B., Reynolds, P. et al. (1999). VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrobial Agents and Chemotherapy 43, 2161-4.
10. Morrison, D., Woodford, N., Barrett, S. P. et al. (1999). DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains, Journal of Clinical Microbiology 37, 1084-91.
11. Polyzou, A., Slavakis, A., Pournaras, S. et al. (2001). Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital. Journal of Antimicrobial Chemotherapy 48, 231-4.
12. Goossens, H., Jabes, D., Rossi, R. et al. (2003). European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. Journal of Antimicrobial Chemotherapy 51, Suppl. 3, 5-12.
13. Gambarotto, K., Ploy, M. C., Turlure, P. et al. (2000). Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France. Journal of Clinical Microbiology 38, 620-4.
14. Gray, J. W. & George, R. H. (2000). Experience of vancomycin-resistant enterococci in a children's hospital. Journal of Hospital Infection 45, 11-8.